Puerto Rico Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
98 Pages - SKU: BMI5325676
Countries covered: Puerto Rico

Puerto Rico Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: Puerto Rico will continue to attract investment from multinational pharmaceutical companiesdue to its tax incentives, relatively low production costs and close ties with the US economy. Drugmakerscan also capitalise on the government's promotion of the local production of generic medicines and biologicdrugs.

Headline Expenditure Projections

Pharmaceuticals: USD3.02bn in 2013 to USD3.02bn in 2014; +0.2% in local currency terms. Forecastis the same as previous quarter's projection.

Healthcare: USD7.76bn in 2013 to USD8.02bn in 2014; +3.4% in local currency terms. Forecast is thesame as previous quarter's projection.



More Prescription Drugs reports by Business Monitor International

Sweden Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sweden Pharmaceuticals and Healthcare Report Q1 2015BMI View: Declining government reimbursement for prescription medicines does not bode well forinnovative drugmakers selling their products in Sweden, ...
Pakistan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Pakistan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Pakistan holds great potential for pharmaceutical and healthcare companies, with the world'ssixth largest population. However, poor medical ...
Nigeria Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Nigeria Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Nigerian government remains committed to improving healthcare quality andinfrastructure across the country. The formation of the ...
New Zealand Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
New Zealand Pharmaceuticals and Healthcare Report Q1 2015BMI View: With New Zealand's population ageing rapidly, underlying demand for health services andpharmaceuticals is high for the ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!